Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
Clinical trial NCT00903292 · UNKNOWN
Trial details
- NCT number
- NCT00903292
- Sponsor
- National Cheng-Kung University Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-04-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.